about
Structural characterization and mutational assessment of podocin - a novel drug target to nephrotic syndrome - an in silico approachPDB explorer -- a web based algorithm for protein annotation viewer and 3D visualization.Alkyloxy carbonyl modified hexapeptides as a high affinity compounds for Wnt5A protein in the treatment of psoriasis.Implications of a novel Pseudomonas species on low density polyethylene biodegradation: an in vitro to in silico approachStructural basis for the in vitro known acyl-depsipeptide 2 (ADEP2) inhibition to Clp 2 protease from Mycobacterium tuberculosisComputational evaluation of new homologous down regulators of Translationally Controlled Tumor Protein (TCTP) targeted for tumor reversion.A Virtual Screening approach for the Identificationof High affinity small molecules targeting BCR-ABL1 inhibitors for the treatment of Chronic Myeloid Leukemia.Helix-coil transition signatures BRAF V600E mutation and virtual screening for inhibitors directed against mutant BRAF.Identification of high affinity bioactive Salbutamol conformer directed against mutated (Thr164Ile) beta 2 adrenergic receptor.Identification of LOGP values and Electronegativities as structural insights to model inhibitory activity of HIV-1 capsid inhibitors - a SVM and MLR aided QSAR studies.Identification of Small Molecule as a High Affinity β2 Agonist Promiscuously Targeting Wild and Mutated (Thr164Ile) β 2 Adrenergic Receptor in the Treatment of Bronchial Asthma.Insights from the predicted epitope similarity between Mycobacterium tuberculosis virulent factors and its human homologs.Screening, isolation and identification of Probiotic producing lactobacillus acidophilus strains EMBS081 & EMBS082 by 16S rRNA gene sequencing.Screening, Isolation and Identification of Probiotic Producing Lactobacillus acidophilus Strains EMBS081 & EMBS082 by 16S rRNA Gene Sequencing.Molecular Docking and Pharmacological Investigations of Rivastigmine-Fluoxetine and Coumarin-Tacrine hybrids against Acetyl Choline Esterase.Molecular docking based screening of GABA (A) receptor inhibitors from plant derivatives.An in silico approach for identification of novel inhibitors as a potential therapeutics targeting HIV-1 viral infectivity factor.Molecular docking analysis of RN18 and VEC5 in A3G-Vif inhibition.Molecular docking approaches in identification of High affinity inhibitors of Human SMO receptor.Structure based virtual screening of ligands to identify cysteinyl leukotriene receptor 1 antagonist.Molecular dynamic simulations reveal suboptimal binding of salbutamol in T164I variant of β2 adrenergic receptor.Binding modes and pharmacophoric features of muscarinic antagonism and β2 agonism (MABA) conjugates.Editorial (Thematic Issue: Chemoinformatics Models for Pharmaceutical Design, Part 1).Editorial (Thematic Issue: Chemoinformatics Models for Pharmaceutical Design, Part 2).Editorial: Improving Neuropharmacology using Big Data, Machine Learning and Computational Algorithms.Identification and Characterization of a Pesticide Degrading Flavobacterium Species EMBS0145 by 16S rRNA Gene Sequencing.Erratum to: Identification and characterization of alkaline protease producing bacillus firmus species EMBS023 by 16S rRNA gene sequencing.Isolation and characterization of a novel chlorpyrifos degrading flavobacterium species EMBS0145 by 16S rRNA gene sequencing.Identification and characterization of alkaline protease producing Bacillus firmus species EMBS023 by 16S rRNA gene sequencing.Multiclass comparative virtual screening to identify novel Hsp90 inhibitors: a therapeutic breast cancer drug target.Global QSAR modeling of logP values of phenethylamines acting as adrenergic alpha-1 receptor agonists.Common SAR Derived from Linear and Non-linear QSAR Studies on AChE Inhibitors used in the Treatment of Alzheimer's Disease.Development of MLR and SVM Aided QSAR Models to Identify Common SAR of GABA Uptake Herbal Inhibitors used in the Treatment of Schizophrenia.Common SAR Derived from Multiple QSAR Models on Vorinostat Derivatives Targeting HDACs in Tumor Treatment.Association of Beta 2 adrenergic receptor (Thr164Ile) polymorphism with Salbutamol refractoriness in severe asthmatics from Indian population.Identification and characterization of a pesticide degrading flavobacterium species EMBS0145 by 16S rRNA gene sequencing.Editorial (Thematic Issue: Mechanistics in Drug Design - Experimental Molecular Biology vs. Molecular Modeling)Natural Bioactive Products with Antioxidant Properties Useful in Neurodegenerative Diseases.Identification of Potent VEGF Inhibitors for the Clinical Treatment of Glioblastoma, A Virtual Screening ApproachIdentification of High-Affinity Small Molecule Targeting IDH2 for the Clinical Treatment of Acute Myeloid Leukemia
P50
Q28306636-42999F46-4473-4C08-A6FA-33248FB17D89Q30365661-ED3C32C0-8642-48A1-B2A1-68B1119B59C5Q35033149-F7418B69-A780-4F99-BDE4-E5957C97E26FQ35537548-7744414A-8D1C-4BF4-8FB3-8B4DCB9C08BDQ37608263-20B1FBDE-FB0E-4D0E-BFD3-6C070E72651AQ38451138-609DEF32-4342-4433-BCCF-747736733F04Q38614583-25F8B5D3-2D9B-4D87-A9CF-39F9BD3F1050Q38803618-5B1A5111-ADE4-48F2-9342-61B946AF863BQ39061587-0E336546-2D4E-4D33-85C6-D93A0F999C15Q39266891-08482924-1AB5-410E-BCA7-6D349E4D4A9EQ39769881-4907A801-BA20-4CAE-A577-658AC29FAC09Q40105286-5594F371-B978-4B4F-B78E-8261536A8E65Q40223414-71D5D8A6-2929-4DE8-8A26-A3BC80543811Q40298792-109893A2-BC8A-4026-9B84-75875C46F032Q40484350-6043C5F6-2891-4443-9019-17C1DD428D53Q40674790-D030B747-C0E7-4BD3-A694-E549796F4EF8Q41550402-0266DE99-DF41-4800-8D39-0E3B76260545Q41609219-64BB5214-522F-4CEE-B359-D58DAF29393AQ42702608-0388EED0-4652-405C-A980-DB1E1D5E7E69Q43044477-1C0088A0-972E-4A3E-AA98-C47691C589C7Q43849764-FFFD62DF-FEBB-44DB-B586-223CD58E2D8BQ43980461-EFACA4F1-7107-4E1B-B4AB-DC5AE23772A2Q45047185-93AF27F9-68F1-4E22-A681-1E932D830BA3Q45047188-214BAC1C-7C11-4816-B170-94FF1C15BC12Q45943327-709841B7-FDC1-4F32-B80C-4D1B523DB607Q46696360-42E68271-6DCE-4559-8B99-705A0CF96F13Q46756302-FAF59015-94AB-4E40-8A1A-9F9A02DA1400Q46834927-0B8FFC97-A495-4720-A995-115BC0FBFB58Q46852764-BA24F7B3-C8F2-4197-92A8-8418080E7809Q47958936-15D05B20-008A-4CCA-933E-0F4FAF98B55CQ48039060-991ABB3F-C9C6-4515-B65C-B8F222F9597EQ48396854-EECBB950-C577-4848-BE7A-BD4B20545AE3Q48912516-D170CCC7-7E2C-4628-A2DB-DD07ECBC1857Q50793336-F0BCA5F5-2A3D-4E52-B973-5F45B0E93A1FQ51621059-D7A869C8-F526-42E1-951D-D4F2FAA8C9EEQ52777521-20347B6D-5DB8-48E9-BFBF-5B2483374DBDQ62757078-A197D251-9BD4-4B67-A787-027989CD2BA5Q64928983-0BCB0F6A-B1BD-465C-98B0-A7F63C5840EFQ90284778-66B7CEDE-BBEB-4859-84F2-54DA001D7C29Q92876929-99FF7D0E-E812-4F4E-B162-F603C4D42552
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Anuraj Nayarisseri
@ast
Anuraj Nayarisseri
@en
Anuraj Nayarisseri
@es
Anuraj Nayarisseri
@nl
Anuraj Nayarisseri
@sl
type
label
Anuraj Nayarisseri
@ast
Anuraj Nayarisseri
@en
Anuraj Nayarisseri
@es
Anuraj Nayarisseri
@nl
Anuraj Nayarisseri
@sl
altLabel
Anuraj Nayarisseri S
@en
prefLabel
Anuraj Nayarisseri
@ast
Anuraj Nayarisseri
@en
Anuraj Nayarisseri
@es
Anuraj Nayarisseri
@nl
Anuraj Nayarisseri
@sl
P1053
A-4190-2016
P106
P31
P3829
P496
0000-0003-2567-9630